Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „determined“
Suchtreffer
Begriffe & Kennungen
Aranesp · 4.8 · Adverse reactions were determined based on pooled data from eight randomised, double-blind, placebo-controlled
Eintrag öffnenAripiprazole Sandoz · 4.8 · The frequency of adverse reactions reported during post-marketing use cannot be determined as they are derived
Eintrag öffnenAtypische Plattenepithel-Zellen der Zervix
Eintrag öffnenAvastin · 4.8 · Table 1 provides all adverse reactions by frequency that were determined to have a causal relationship with Av
Eintrag öffnenEpclusa · 4.8 · The safety profile of Epclusa has been determined in pooled Phase 3 clinical studies of patients with genotype
Eintrag öffnenEpclusa · 4.8 · The safety profile of Epclusa has been determined in pooled Phase 3 clinical studies of patients with genotype
Eintrag öffnenEptifibatide Accord · 4.8 · Note that causality has not been determined for all adverse reactions.
Eintrag öffnenEptifibatide Accord · 4.8 · Note that causality has not been determined for all adverse reactions.
Eintrag öffnenFarydak · 4.8 · Neutropenia Neutropenia was frequently reported on the basis of laboratory findings determined during the stud
Eintrag öffnenKlonale Hämatopoese
Eintrag öffnenMavenclad · 4.8 · To decrease the risk for severe lymphopenia, lymphocyte counts must be determined before, during and after cla
Eintrag öffnenMonoklonale Gammopathien, benigne
Eintrag öffnenMvasi · 4.8 · Table 1 provides all adverse reactions by frequency that were determined to have a causal relationship with be
Eintrag öffnenOlazax · 4.8 · 11 Adverse event identified from spontaneous post-marketing reporting with frequency determined utilising the
Eintrag öffnenOlazax · 4.8 · 11 Adverse event identified from spontaneous post-marketing reporting with frequency determined utilising the
Eintrag öffnenOtezla · 4.8 · The adverse drug reactions were determined based on data from the apremilast clinical development programme an
Eintrag öffnenPraluent · 4.8 · The frequency of adverse reactions reported during post-marketing use cannot be determined as they are derived
Eintrag öffnenSamsca · 4.8 · The frequency of adverse reactions reported during post-marketing use cannot be determined as they are derived
Eintrag öffnenSprycel · 4.8 · determined whether these mucocutaneous adverse reactions were directly related to SPRYCEL or to concomitant me
Eintrag öffnenSprycel · 4.8 · determined whether these mucocutaneous adverse reactions were directly related to SPRYCEL or to concomitant me
Eintrag öffnen